Table 2. Cancer Cell Lines and Screening Dataa.
neoplasia | cell lines | assayed CPDs | active CPDs | inactive CPDs | |
---|---|---|---|---|---|
1 | breast | 6 | 161 953 | 10 031 | 151 922 |
2 | CNS | 8 | 265 511 | 13 865 | 251 646 |
3 | colon | 9 | 310 533 | 17 070 | 293 463 |
4 | leukemia | 8 | 231 398 | 20 082 | 211 316 |
5 | melanoma | 10 | 360 686 | 18 693 | 341 993 |
6 | nonsmall cell lung | 11 | 378 082 | 19 683 | 358 399 |
7 | ovarian | 7 | 242 571 | 12 446 | 230 125 |
8 | prostate | 2 | 56 284 | 3195 | 53 089 |
9 | renal | 10 | 324 513 | 16 244 | 308 269 |
10 | small cell lung | 2 | 27 527 | 1882 | 25 645 |
The table provides statistics for the 10 neoplasia types and corresponding screening data. For each neoplasia, the name and number of cell lines are given. In addition, the total number of assayed compounds (CPDs) and the number of active and inactive compounds are reported.